MTF transition hormones: lifesaving or harmful to the liver?

Forum data reveal a growing tension between the life-saving benefit and the liver costs of hormone therapy in male-to-female trans people

The debate over hormones in trans people is nothing new, but a recent exchange pits two radically opposed positions against each other: on one side, the claim that «many of those trans people would be living dead without hormones»; on the other, the warning that the liver and other organs «must be wrecked by that mix of artificial hormones». The discussion focuses on male-to-female (MTF) transition, leaving other cases out.

Those who defend the hormones stress the debilitating nature of gender dysphoria: a condition that, untreated, condemns sufferers to an unbearable existence. The argument is no small matter: hormone therapy is not a whim, but a matter of psychological and social survival. «Most come out ahead», it is stated, although it is acknowledged that not all cases are successful.

On the opposite side, medical warnings arise about long-term liver risks. It is pointed out that the liver – the body's main hormone-metabolizing organ – can suffer cumulative damage, especially with oral administration. However, one participant, in a technical tone, replies that the risk depends on the route: non-oral routes minimize the hepatic pass. Testicular atrophy and estrogen dominance are presented as inevitable consequences, but not necessarily pathological ones.

What appears nowhere are clinical documents or medical consensus: the debate is fought with personal impressions and anecdotes. There are no prevalence figures, nor success or complication rates either. The lack of reliable data is as loud as the clashing opinions.

The exchange descends into homophobic insults and mutual disparagement, but that does not invalidate the substance: the real question is whether the benefits of hormone therapy outweigh the physiological costs in each individual case. Without long-term population studies, every trans person is left to their own devices and to those of their endocrinologist.

The pending dilemma

Neither side offers a solution. While one holds that therapy is essential to avoid losing one's life, the other warns that the treatment may shorten it by another route. The debate is left hanging, without confronting the real medical evidence which – if it exists – is conspicuously absent from the discussion. Until medicine provides solid data, each patient will keep making their own particular bet.

Related debates in the forum

• ME HAN PUESTO EN EL IGNORE (X) · 19702 replies
• Hilo del real madrid 2025/26. año i después de modric y cesard. el advenimiento de franco. · 84607 replies
• ⚡ Torneo Deluxe 4ra Edicion ⚡ (abiertas las suscripciones) · 2883 replies
• Lydia Bosch es ya una granny de 63 años, pero la amarias · 59 replies